Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

Similar articles for PubMed (Select 21331509)

1.

Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability.

Ge J, Tan BX, Chen Y, Yang L, Peng XC, Li HZ, Lin HJ, Zhao Y, Wei M, Cheng K, Li LH, Dong H, Gao F, He JP, Wu Y, Qiu M, Zhao YL, Su JM, Hou JM, Liu JY.

J Mol Med (Berl). 2011 Jun;89(6):595-602. doi: 10.1007/s00109-011-0737-3. Epub 2011 Feb 18.

PMID:
21331509
2.

Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.

Lee SC, Chan WK, Lee TW, Lam WH, Wang X, Chan TH, Wong YC.

Nutr Cancer. 2008;60(4):483-91. doi: 10.1080/01635580801947674.

PMID:
18584482
3.

Studies on the effects of oral administration of nutrient mixture, quercetin and red onions on the bioavailability of epigallocatechin gallate from green tea extract.

Kale A, Gawande S, Kotwal S, Netke S, Roomi W, Ivanov V, Niedzwiecki A, Rath M.

Phytother Res. 2010 Jan;24 Suppl 1:S48-55. doi: 10.1002/ptr.2899. Erratum in: Phytother Res. 2010 Apr;24(4):632.

PMID:
19585479
4.

Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice.

Lambert JD, Kim DH, Zheng R, Yang CS.

J Pharm Pharmacol. 2006 May;58(5):599-604.

PMID:
16640828
5.

Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice.

Lambert JD, Hong J, Kim DH, Mishin VM, Yang CS.

J Nutr. 2004 Aug;134(8):1948-52.

6.

Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats.

Meng X, Sang S, Zhu N, Lu H, Sheng S, Lee MJ, Ho CT, Yang CS.

Chem Res Toxicol. 2002 Aug;15(8):1042-50.

PMID:
12184788
7.

Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats.

Misaka S, Miyazaki N, Fukushima T, Yamada S, Kimura J.

Phytomedicine. 2013 Nov 15;20(14):1247-50. doi: 10.1016/j.phymed.2013.07.003. Epub 2013 Aug 3.

PMID:
23920278
8.

Green tea polyphenol (-)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia.

Park JW, Hong JS, Lee KS, Kim HY, Lee JJ, Lee SR.

J Nutr Biochem. 2010 Nov;21(11):1038-44. doi: 10.1016/j.jnutbio.2009.08.009. Epub 2009 Dec 4.

PMID:
19962294
9.

Tea polyphenol (-)-epigallocatechin-3-gallate: a new trapping agent of reactive dicarbonyl species.

Sang S, Shao X, Bai N, Lo CY, Yang CS, Ho CT.

Chem Res Toxicol. 2007 Dec;20(12):1862-70. Epub 2007 Nov 15.

PMID:
18001060
10.

Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.

Fassina G, Venè R, Morini M, Minghelli S, Benelli R, Noonan DM, Albini A.

Clin Cancer Res. 2004 Jul 15;10(14):4865-73.

11.

Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions.

Sang S, Lee MJ, Hou Z, Ho CT, Yang CS.

J Agric Food Chem. 2005 Nov 30;53(24):9478-84.

PMID:
16302765
12.

Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.

Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.

Cancer Lett. 2007 Jan 8;245(1-2):232-41. Epub 2006 Mar 6.

PMID:
16519995
13.

Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.

Chow HH, Cai Y, Hakim IA, Crowell JA, Shahi F, Brooks CA, Dorr RT, Hara Y, Alberts DS.

Clin Cancer Res. 2003 Aug 15;9(9):3312-9.

14.

Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.

Chow HH, Cai Y, Alberts DS, Hakim I, Dorr R, Shahi F, Crowell JA, Yang CS, Hara Y.

Cancer Epidemiol Biomarkers Prev. 2001 Jan;10(1):53-8.

15.

Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy.

Williamson MP, McCormick TG, Nance CL, Shearer WT.

J Allergy Clin Immunol. 2006 Dec;118(6):1369-74. Epub 2006 Oct 13.

PMID:
17157668
17.

Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts.

Yun JH, Pang EK, Kim CS, Yoo YJ, Cho KS, Chai JK, Kim CK, Choi SH.

J Periodontal Res. 2004 Oct;39(5):300-7.

PMID:
15324350
18.

Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro.

Qiao J, Gu C, Shang W, Du J, Yin W, Zhu M, Wang W, Han M, Lu W.

Food Chem Toxicol. 2011 Jun;49(6):1410-5. doi: 10.1016/j.fct.2011.03.033. Epub 2011 Mar 31.

PMID:
21440026
19.

Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals.

Henning SM, Niu Y, Liu Y, Lee NH, Hara Y, Thames GD, Minutti RR, Carpenter CL, Wang H, Heber D.

J Nutr Biochem. 2005 Oct;16(10):610-6.

PMID:
16081270
20.

The acid-promoted reaction of the green tea polyphenol epigallocatechin gallate with nitrite ions.

Panzella L, Manini P, Napolitano A, d'Ischia M.

Chem Res Toxicol. 2005 Apr;18(4):722-9.

PMID:
15833032
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk